Population
In vitro models including Escherichia coli expressing the Lb form of the leader proteinase and eIF-4 gamma…
Comparison
Purification of the Lb form of the leader… vs Human rhinovirus type 2 2A proteinase and in…
Design
Preclinical
Authors
Loading...
May enable selective FMDV inhibitors; extends picornavirus protease maps but leaves open therapeutic translation.
The study identifies the specific cleavage site of the foot-and-mouth disease virus leader proteinase on eIF-4 gamma, highlighting a distinct mechanism from other picornaviruses.
Kirchweger et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: